Omeros Corporation
OMER
#6583
Rank
A$1.21 B
Marketcap
A$16.85
Share price
-0.75%
Change (1 day)
202.48%
Change (1 year)

Omeros Corporation (OMER) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.49 Billion

According to Omeros Corporation's latest financial reports the company's total liabilities are A$0.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Omeros Corporation - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.66 B-9.73%
2024-12-31A$0.73 B24.86%
2023-12-31A$0.59 B-20.29%
2022-12-31A$0.74 B36.11%
2021-12-31A$0.54 B38.99%
2020-12-31A$0.39 B11.71%
2019-12-31A$0.35 B26.22%
2018-12-31A$0.27 B82.4%
2017-12-31A$0.15 B5.04%
2016-12-31A$0.14 B40.69%
2015-12-31A$0.10 B58%
2014-12-31A$65.35 M66.95%
2013-12-31A$39.14 M22.88%
2012-12-31A$31.85 M0.4%
2011-12-31A$31.73 M27.73%
2010-12-31A$24.84 M17.97%
2009-12-31A$21.05 M-86.83%
2008-12-31A$0.15 B44.01%
2007-12-31A$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$170.39 B 34,150.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$166.84 B 33,436.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
A$4.14 M-99.17%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
A$5.24 M-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA